« Back
Home /
JND3229

JND3229

Item no.	DCC-DC12804-25mg
Manufacturer	DCChemicals
CASRN	2260886-64-2
Amount	25 mg
Quantity options	100 mg 10 mM x 1 mL in DMSO 10 mg 1 g 250 mg 25 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Applications	IV
Specific against	other
Purity	>98%
Smiles	ClC1=C([H])C([H])=C([H])C([H])=C1N1C([H])([H])C2=C([H])N=C(N([H])C3C([H])=C([H])C(=C(C([H])([H])[H])C=3[H])N3C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C3([H])[H])N=C2N(C1=O)C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])N([H])C(C([H])([
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	JND3229,JND-3229,JND 3229
Similar products	2260886-64-2
Available
Manufacturer - Applications	JND3229 is a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy (IC50 = 5.8 nM).
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	617, 184
Note	For research and scientific purpose only, not for human use.
Chemical name	N-((1r, 4r)-4-(3-(2-chlorophenyl)-7-((3-methyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-2-oxo-3, 4-dihydropyrimido[4, 5-d]pyrimidin-1(2H)-yl)cyclohexyl)propionamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Delivery expected until 9/11/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer